Professor of Law and Faculty Director, Global Health Justice Partnership
(on leave, fall 2016)
Amy Kapczynski is a Professor of Law at Yale Law School and faculty director of the Global Health Justice Partnership. Her areas of research including information policy, intellectual property law, international law, and global health.FULL BIOGRAPHY
Yale Law School
P.O. Box 208215
New Haven, CT 06520
- Room L25
- (203) 432-8005
Education & Curriculum Vitae
J.D., Yale Law School, 2003
M.A., Queen Mary and Westfield College, University of London, 1998
M. Phil., University of Cambridge, 1997
A.B., Princeton University, 1996
- International Intellectual Property Law
- Law and Social Movements
- Global Health and Justice Practicum
- Intellectual Property: The Law of Scientific and Cultural Production
Amy Kapczynski is a Professor of Law at Yale Law School and faculty director of the Global Health Justice Partnership. She joined the Yale Law faculty in January 2012. Her areas of research including information policy, intellectual property law, international law, and global health. Prior to coming to Yale, she taught at the University of California, Berkeley, School of Law. She also served as a law clerk to Justices Sandra Day O'Connor and Stephen G. Breyer at the U.S. Supreme Court, and to Judge Guido Calabresi on the U.S. Court of Appeals for the Second Circuit. She received her A.B. from Princeton University, M. Phil. from Cambridge University, M.A. from Queen Mary and Westfield College at University of London, and J.D. from Yale Law School.
Wednesday, February 10, 2016
The Collaboration for Research Integrity and Transparency (CRIT) at Yale University, a new initiative launching in July 2016, received a $3 million grant from the Laura and John Arnold Foundation (LJAF) to promote open access to high-quality data in health.
Thursday, December 3, 2015
A report released today examining the U.S. response to the 2014–2015 Ebola epidemic warns against politically motivated and scientifically unwarranted quarantines, which the report found violated individuals’ rights and hampered efforts to fight the disease by discouraging American doctors and nurses from going abroad.
Thursday, June 25, 2015
Treatment Action Group and the Global Health Justice Partnership have filed a federal lawsuit for access to the information that Gilead Sciences submitted to the FDA on two new—and extremely expensive—hepatitis C drugs, Sovaldi and Harvoni.
Thursday, February 12, 2015
Yale Law School launches its first ever food law and policy class in response to strong student interest in this growing area of law.
Tuesday, October 7, 2014
The Public Health in the Shadow of the First Amendment Conference will take place at Yale Law School on October 17 and 18.
Monday, February 24, 2014
It’s a cold day in December, and nearly two dozen student and post-graduate fellows from six of Yale University’s professional schools have gathered at the Law School for a colloquium lunch with faculty members to discuss the work of global health justice, an emerging discipline located at the intersection of law, public health, and policy advocacy. The event is part of the programming and coursework organized by the Yale Global Health Justice Partnership (GHJP), a new collaborative effort between Yale Law School and the Yale School of Public Health (YSPH).
Monday, March 21, 2011
MSNBC TV host Rachel Maddow will be at Yale Law School on March 28 for a Q&A with Visiting Associate Professor Amy Kapczynski ’03.
‘Government Patent Use’: A Legal Approach To Reducing Drug Spending’, Health Affairs, Mar. 2 2016
Innovation Sticks: The Limited Case for Penalizing Failures to Innovate, 81 Chi. L. Rev. 1781 (2015) (with Ian Ayres)
The Trans-Pacific Partnership — Is it Bad for Your Health?, New England Journal of Medicine (July 16, 2015)
Free Speech and Pharmaceutical Regulation: Fishy Business, JAMA Internal Medicine (March 2016)
Resist Pressure at Any Price, Business Today (India), Jan. 17, 2016 (with David Grewal)
Engineered in India: Patent Law 2.0, New Eng. J. Med. (July 17, 2013).
The Continuum of Excludability and the Limits of Patents, 120 Yale L. J. 1900 (2013) (with Talha Syed)
The Cost of Price: Why and How to Get Beyond Intellectual Property Internalism, 59 UCLA L. Rev. 970 (2012)
“Access to Knowledge: A Conceptual Genealogy,” in Access to Knowledge in the Age ofIntellectual Property (Zone Press 2010, Gaëlle Krikorian and Amy Kapczynski, eds.)
Harmonization and its Discontents: A Case Study of TRIPS Implementation in India’s Pharmaceutical Sector, 97 Calif. L. Rev. 1571 (2009)
The Access to Knowledge Mobilization and the New Politics of Intellectual Property, 117 Yale L. J. 804 (2008)
Addressing Global Health Inequities: An Open Licensing Approach for University Innovations, 20 Berkeley Tech. L.J. 1031 (2005) (with Samantha Chaifetz, Zachary Katz, & Yochai Benkler)
Historicism, Progress, and the Redemptive Constitution, 26 Cardozo L. Rev. 1041 (2005)
Access to Knowledge in the Age of Intellectual Property (Zone Press 2010, Gaëlle Krikorian and Amy Kapczynski, eds.)
The Story of the TAC Case: The Potential and Limits of Socio-Economic Rights Litigation in South Africa, in Human Rights Advocacy Stories (Foundation Press 2009) (with Jonathan Berger)
Commentary: Innovation Policy for a New Era, 37 J. of Law, Medicine & Ethics 264 (June 2009)
Is Bayh-Dole Good for Developing Countries? Lessons from the US Experience, 6 Plos Biology e262 (Oct. 1, 2008) (with Anthony D. So, Bhaven N. Sampat, Arti K. Rai, Robert Cook-Deegan, Jerome H. Reichman, and Robert Weissman)
The Access to Knowledge Mobilization and the New Politics of Intellectual Property, 117 Yale L.J. Pocket Part 262 (2008)
Linking Ideas to Outcomes: A Response, 117 Yale L.J. Pocket Part 289 (2008)